Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,841 | 227 | 80.2% |
| Education | $1,446 | 16 | 19.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $801.89 | 20 | $0 (2024) |
| Seagen Inc. | $654.42 | 17 | $0 (2023) |
| Amgen Inc. | $576.81 | 11 | $0 (2022) |
| Janssen Biotech, Inc. | $499.90 | 14 | $0 (2022) |
| Daiichi Sankyo Inc. | $448.78 | 7 | $0 (2024) |
| Celgene Corporation | $435.37 | 16 | $0 (2023) |
| Lilly USA, LLC | $395.40 | 21 | $0 (2022) |
| BeiGene USA, Inc. | $375.00 | 3 | $0 (2022) |
| Incyte Corporation | $340.02 | 12 | $0 (2022) |
| Merck Sharp & Dohme LLC | $326.68 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $517.64 | 6 | Exelixis Inc. ($135.00) |
| 2023 | $389.86 | 12 | Daiichi Sankyo Inc. ($125.00) |
| 2022 | $3,328 | 115 | AstraZeneca Pharmaceuticals LP ($466.99) |
| 2021 | $3,052 | 110 | Lilly USA, LLC ($333.33) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 03/29/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $99.99 | General |
| 03/21/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Oncology | ||||||
| 03/14/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: Oncology | ||||||
| 07/14/2023 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Oncology | ||||||
| 04/28/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $27.03 | General |
| Category: Hematology | ||||||
| 03/22/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Oncology | ||||||
| 03/17/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 03/03/2023 | PFIZER INC. | INLYTA (Drug), BAVENCIO, LORBRENA | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $23.27 | General |
| Category: Hematology | ||||||
| 02/08/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: HORMONE THERAPY | ||||||
| 01/27/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $24.80 | General |
| 01/04/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Oncology | ||||||
| 12/16/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $11.83 | General |
| Category: Oncology | ||||||
| 12/13/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 12/10/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $24.53 | General |
| Category: Oncology | ||||||
| 11/30/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2022 | PFIZER INC. | IBRANCE (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Oncology | ||||||
| 11/05/2022 | PFIZER INC. | INLYTA (Drug), BAVENCIO, LORBRENA | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: ONCOLOGY | ||||||
About Margaret Tam, NURSE PRACTITIONER
Margaret Tam, NURSE PRACTITIONER is a Family healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2020. The National Provider Identifier (NPI) number assigned to this provider is 1215542923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Margaret Tam, NURSE PRACTITIONER has received a total of $7,287 in payments from pharmaceutical and medical device companies, with $517.64 received in 2024. These payments were reported across 243 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,841).
Practice Information
- Specialty Family
- Location Staten Island, NY
- Active Since 09/10/2020
- Last Updated 09/10/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1215542923
Products in Payments
- BRUKINSA (Drug) $375.00
- Enhertu (Drug) $375.00
- TAGRISSO (Drug) $342.50
- KEYTRUDA (Biological) $326.68
- IMFINZI (Biological) $326.09
- OPDIVO (Biological) $226.47
- JEVTANA (Drug) $225.34
- LUMAKRAS (Drug) $201.75
- REBLOZYL (Biological) $200.45
- PROMACTA (Drug) $196.92
- ERLEADA (Drug) $181.07
- MONJUVI (Drug) $176.91
- CABOMETYX (Drug) $169.42
- Tavalisse (Drug) $167.29
- Lenvima (Drug) $160.41
- TUKYSA (Drug) $156.67
- IMBRUVICA (Drug) $154.42
- ORGOVYX (Drug) $143.83
- CYRAMZA (Drug) $138.28
- DARZALEX (Biological) $137.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Staten Island
John De Oca, Fnp-Bc, FNP-BC
Family — Payments: $85,658
Briana Damora, Fnp, FNP
Family — Payments: $9,706
Mrs. Christine Lutrario, Np, NP
Family — Payments: $8,508
Emily Kennedy, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $8,438
Barbara Casuso, Fnp, FNP
Family — Payments: $7,856
Mr. Dave Amarasena, Np, NP
Family — Payments: $7,534